| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| ANCR |
|
Angelman syndrome chromosome region
|
|
|
0.751 |
0.154 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| HOXA@ |
|
homeobox A cluster
|
|
|
0.599 |
0.654 |
| HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| PTPRZ2 |
|
protein tyrosine phosphatase receptor type Z2
|
|
|
0.792 |
0.269 |
| SNORD15A |
|
small nucleolar RNA, C/D box 15A
|
|
|
0.653 |
0.577 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TRP-AGG2-6 |
|
tRNA-Pro (anticodon AGG) 2-6
|
|
|
0.666 |
0.462 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| BAS |
|
Beta-adrenergic stimulation, response to
|
|
|
0.711 |
0.346 |
| DGCR5 |
|
DiGeorge syndrome critical region gene 5
|
|
|
0.650 |
0.577 |
| SNORD48 |
|
small nucleolar RNA, C/D box 48
|
|
|
0.792 |
0.154 |
| HPLH1 |
|
hemophagocytic lymphohistiocytosis 1
|
|
|
0.695 |
0.538 |
| ERVH-4 |
|
endogenous retrovirus group H member 4
|
|
|
0.861 |
0.077 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| TP73-AS1 |
|
TP73 antisense RNA 1
|
|
|
0.599 |
0.577 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |